May 19, 2024, 10:00
Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:
“A comprehensive review of the research history and current status of ponatinib in CML and Ph+ ALL
Elias Jabbour of MD Anderson Comprehensive Cancer Center.”
Source: Hagop Kantarjian/X
Aug 13, 2024, 19:09